Ultragenyx Pharmaceutical
RARE
RARE
205 hedge funds and large institutions have $5.2B invested in Ultragenyx Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 82 increasing their positions, 65 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $4.94B → $5.2B (+$256M)
1.43% less ownership
Funds ownership: 105.79% → 104.35% (-1.4%)
Holders
205
Holding in Top 10
–
Calls
$5.91M
Puts
$2.92M
Top Buyers
| 1 | +$56.1M | |
| 2 | +$19.9M | |
| 3 | +$18M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.5M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$9.71M |
Top Sellers
| 1 | -$40.6M | |
| 2 | -$22.4M | |
| 3 | -$19.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$13.5M |